)
Edge
Extra Everything: The Story of Chipotle
Chipotle's story from a single restaurant to a nationwide chain, through crisis and turnaround, built on one of the strongest models in the industry.
Protagonist Therapeutics
Protagonist Therapeutics (PTGX) investor relations material
Protagonist Therapeutics AGM 2026 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.AGM 2026 summary17 Jun, 2026
Opening remarks and agenda
The meeting was called to order by Matthew Gosling, EVP and Chief Legal and Business Officer, who introduced the board, executive officers, and external representatives in attendance.
The meeting was held virtually, allowing stockholders to submit questions and vote online.
The agenda included four proposals: election of directors, advisory vote on executive compensation, ratification of the auditor, and approval of the equity incentive plan.
Board and executive committee updates
Board members present included Dr. Dinesh Patel (President & CEO), Harold Selick, Bryan Giraudo, Sarah O'Dowd, William Waddill, and Lewis Williams.
Executive officers present were Dr. Patel, Asif Ali, and Arturo Molina.
Shareholder proposals
Four proposals were presented: election of two Class I directors, advisory approval of executive compensation, ratification of Ernst & Young as auditor, and adoption of the 2026 equity incentive plan.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Protagonist Therapeutics
- Icotyde's strong launch and a robust pipeline drive growth, with Rusfertide approval expected soon.PTGX
Goldman Sachs 47th Annual Global Healthcare Conference 202610 Jun 2026 - Major partnerships, strong pipeline, and financial strength drive growth and shareholder returns.PTGXJefferies Global Healthcare Conference 20263 Jun 2026
- ICOTYDE and Rusfertide drive near-term growth, with a robust pipeline and strong financials.PTGXCompany presentation3 Jun 2026
- ICOTYDE approval and rusfertide milestones drove Q1 profitability and a strong cash position.PTGXQ1 20265 May 2026
- FDA approved ICOTYDE, the first oral IL-23R antagonist, for moderate-to-severe plaque psoriasis.PTGXFDA announcement4 May 2026
- Virtual annual meeting to vote on directors, compensation, auditor, and equity plan.PTGXProxy filing28 Apr 2026
- Shareholders will vote on directors, executive pay, auditor ratification, and a new equity plan.PTGXProxy filing28 Apr 2026
- Two blockbuster launches, pipeline expansion, and strong cash position drive near-term growth.PTGX44th Annual J.P. Morgan Healthcare Conference12 Apr 2026
- Lead peptide assets near approval as diversified pipeline and partnerships drive future growth.PTGXBarclays 28th Annual Global Healthcare Conference12 Mar 2026
Next Protagonist Therapeutics earnings date
Q2 20263 Aug, 2026
Protagonist Therapeutics
Next Protagonist Therapeutics earnings date
Q2 20263 Aug, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
)
Frequently asked questions
Explore our global coverage